Molecular diagnostics market : Get In-Depth Analysis of How Pandemics Increase the need for diagnostics market

Molecular diagnostic is a collection of techniques used to analyze biological markers in genome and proteome. It helps to diagnose and monitor diseases and helps decide which therapy should be administered to the patient. However, the rising prevalence of the infectious disease, increasing awareness regarding molecular diagnostic techniques, and advancement in molecular diagnostics are the primary factors responsible for market growth during the forecast period.

TheGlobal Molecular Diagnostics Marketis expected to register aCAGR of8.57%and is anticipated to reachUSD 16,319.09 Million by 2025.

The rising prevalence of infectious diseases, rising incidence of different types of cancer, and advancements in molecular diagnostic techniques are the major drivers propelling market growth. However, stringent regulatory policies constrain the growth of the market.

However, the growing frequency of the infectious virus, increasing awareness regarding molecular diagnostic techniques, and development in molecular diagnostics are the primary factors responsible for market growth during the projection period. PCR-based systems are used to detect the etiologic agents of disease directly from clinical samples without the use of culture media.

Request FREE Sample Copy: https://www.reportocean.com/industry-verticals/sample-request?report_id=MRF118

Market segmentation
The Global Molecular Diagnostics Market has been segmented into product, technique, application, end user and by region.

Global Molecular Diagnostics Market, by Product

• Reagents & Kits
• Instruments
• Services & Software

Global Molecular Diagnostics Market, by Technique

• Polymerase Chain Reaction (PCR)
• Isothermal Amplification
• Hybridization
• Sequencing
• Microarray
• Others

Global Molecular Diagnostics Market, by Application

• Infectious Diseases
• Oncology
• Genetic Tests
• Others

Global Molecular Diagnostics Market, by End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Regional Analysis

The global moleculardiagnosticsmarket, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is estimated to dominate the global molecular diagnostics market during the forecast period. This is attributed to the increasing geriatric population and the availability of advanced healthcare facilities in the region.

The Europe market for molecular diagnostics is expected to be the second-largest during the forecast period. The availability of funds for research & development and rising support from the government for the life science sector are expected to boost the growth of the market in this region.

Asia Pacific to register the highest CAGR during the forecast period

Asia-Pacific is estimated to be the fastest-growing market due to developing economies such as China, India, and South Korea emerging as major destinations for the outsourcing of clinical trials, drug manufacturing, and pathology testing. In addition to this, improving healthcare infrastructure has increased the researches being conducted in the region. Moreover, in Asia-Pacific, China accounted for a market share of21.4% in 2018.

The molecular diagnostics market in the Middle East & Africa is expected to witness steady growth during the review period due to a lack of awareness of healthcare facilities.

Key Players

The prominent players in the global moleculardiagnosticsmarket areF.Hoffmann-La Roche Ltd; Hologic, Inc.; QIAGEN; Becton, Dickinson and Company;Abbott Laboratories; Cepheid; Siemens; Thermo Fisher Scientific; and Agilent Technologies. The key strategies followed by the players operating in the global moleculardiagnosticsmarket were innovation, product development, acquisition, and expansion.

Inquiry Before Buying ThisReport@https://www.reportocean.com/industry-verticals/sample-request?report_id=MRF118

Tags: Global Molecular Diagnostics Market